DalsnaFinance › IPOs › Genenta Science S.p.A › IPO

Genenta Science S.p.A. IPO

Completed

Genenta Science S.p.A. completed its initial public offering on NASDAQ on December 15, 2021, pricing at $11.50 a share.

Ticker	GNTA
Exchange	NASDAQ
Status	Completed
Listing date	December 15, 2021
Offering price	$11.50
Shares offered	2,400,000
Total raised	$28M

The offering

Genenta Science S.p.A. sold 2,400,000 shares at $11.50 each on NASDAQ. Multiplied out, that is $27.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $28 million total recorded for the deal.

Company coverage

Genenta Science S.p.A. — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for Genenta Science S.p.A.. This page is general information, not investment advice.